Alector ALEC
NASDAQ ALEC
$2.46 -0.05 (-1.99%)
At close: Sep 4, 2026 · 4:00 PM EDT

Alector (ALEC) Total Liabilities (2018 - 2026)

Alector's (ALEC) quarterly Total Liabilities came in at $212.8 million in Q2 2026, down 25.39% year-over-year from $285.2 million in Q2 2025, and down 7.28% quarter-over-quarter from $229.5 million in Q1 2026.

Analysis

Alector (ALEC) Total Liabilities (2018 - 2026) Analysis & Trends

Alector (ALEC) has reported Total Liabilities for 9 consecutive years, with $212.8 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Total Liabilities fell 25.39% year-over-year to $212.8 million in Q2 2026; TTM through Jun 2026 was $212.8 million, a 25.39% decrease from a year earlier, with the FY2025 full-year figure at $262.6 million, down 23.11% from the prior year.
  • Total Liabilities was $212.8 million for Q2 2026 at Alector, down from $229.5 million in the prior quarter.
  • Over five years, Total Liabilities peaked at $686.9 million in Q1 2022 and troughed at $212.8 million in Q2 2026.
  • A 5-year average of $428.7 million and a median of $438.4 million in 2024 frame the typical range for Total Liabilities.
  • Across the five-year window, Total Liabilities jumped 223.2% in 2022 and slumped 32.11% in 2025, its largest moves.
  • Over 5 years, Total Liabilities stood at $573.2 million in 2022, then slipped by 14.92% to $487.7 million in 2023, then declined by 29.97% to $341.5 million in 2024, then retreated by 23.11% to $262.6 million in 2025, then retreated by 18.95% to $212.8 million in 2026.
  • The last three Total Liabilities figures came in at $212.8 million (Q2 2026), $229.5 million (Q1 2026), and $262.6 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 83.95 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 37.53 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 7.18 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 10.02 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn 1.62 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 4.20 Bn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 4.20 Bn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 13.24 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 1.35 Bn
10 Alector 274.68 Mn 101.88 Mn - 212.83 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 212.83 Mn
Mar 31, 2026 229.53 Mn
Dec 31, 2025 262.59 Mn
Sep 30, 2025 277.57 Mn
Jun 30, 2025 285.25 Mn
Mar 31, 2025 313.69 Mn
Dec 31, 2024 341.50 Mn
Sep 30, 2024 397.09 Mn
Jun 30, 2024 420.16 Mn
Mar 31, 2024 456.59 Mn
Dec 31, 2023 487.67 Mn
Sep 30, 2023 509.84 Mn
Jun 30, 2023 512.43 Mn
Mar 31, 2023 565.33 Mn
Dec 31, 2022 573.21 Mn
Sep 30, 2022 583.93 Mn
Jun 30, 2022 601.16 Mn
Mar 31, 2022 686.92 Mn
Dec 31, 2021 513.93 Mn
Sep 30, 2021 518.34 Mn